ARTICLE | Company News
Ilex and Millennium announce Campath review date
October 26, 2000 7:00 AM UTC
The FDA's Oncologic Drugs Advisory Committee (ODAC) will review on Dec. 14 the companies' BLA for Campath alemtuzumab humanized monoclonal antibody against CD52 to treat advanced B cell chronic lympho...